Exhibit
10.2


 


SELECTIS
HEALTH, INC.


 


NON-STATUTORY
STOCK OPTION AGREEMENT


 


This
Non-Statutory Stock Option Agreement (the “Agreement”) is made and entered into effective the 30th day of March, 2022, between
Selectis Health, Inc. (the “Company”) and Christopher Barker (“Optionee”).


 


NOW,
THEREFORE, it is hereby agreed as follows:


 


1.
Grant of Option. The Company hereby grants to Optionee, as of the date hereof, an option to purchase commencing on the date hereof
and ending on the tenth (10th) anniversary of the date hereof (the “Expiration Date”) an option exercisable to purchase up
to an aggregate of 100,000 shares of Common Stock, $.005 par value, (the “Option Shares”) at an exercise price of $7.00 per
Option Share (the “Exercise Price”). The Option Shares shall be purchasable from time to time during the option term specified
in this Section 1 at the Exercise Price, subject to the vesting provisions of paragraph 3 of this Option.


 


2.
Option Term. This option shall expire at the close of business on the Expiration Date or on the date on which the option shall
have been exercised in full (the “Exercise Date”), unless sooner terminated in accordance with Section 5 hereof.


 


3.
Vesting. This Option is subject to the vesting schedule set forth in this paragraph 3. Only Options that have vested will be exercisable
by Optionee. To vest, Optionee must continue to be the president to the Company on each Vesting Date. The number of Options
to vest on each Vesting Date is as follows:


 


	Number
    of Options	 	Vesting
    Date
	 	 	 
	100,000	 	Immediately
    upon date of grant


 


4.
Limited Transferability.


 


(a)
This option shall be neither transferable nor assignable by Optionee other than by will or the laws of inheritance following Optionee’s
death and may be exercised, during Optionee’s lifetime, only by Optionee. However, Optionee may designate one or more persons as
the beneficiary or beneficiaries of this option, and this option shall, in accordance with such designation, automatically be transferred
to such beneficiary or beneficiaries upon the Optionee’s death while holding this option. Such beneficiary or beneficiaries shall
take the transferred option subject to all the terms and conditions of this Agreement, including (without limitation) the limited time
period during which this option may, pursuant to Section 5, be exercised following Optionee’s death.


 


(b)
If this option is designated a Non-Statutory Option in the Grant Notice, then this option may be assigned in whole or in part during
Optionee’s lifetime to one or more members of Optionee’s family or to a trust established for the exclusive benefit of one
or more such family members or to Optionee’s former spouse, to the extent such assignment is in connection with the Optionee’s
estate plan or pursuant to a domestic relations order. The assigned portion shall be exercisable only by the person or persons who acquire
a proprietary interest in the option pursuant to such assignment. The terms applicable to the assigned portion shall be the same as those
in effect for this option immediately prior to such assignment.


 




    	 



     


    

 


5.
Cessation of Service. The option term specified in Section 1 survives any cessation of services; the vested portion of the option
shall continue to have the term of exercise as determined by Section 1 including any transfer to heirs or beneficiary’s.


 


6.
Adjustment in Option Shares. Should any change be made to the Common Stock by reason of any stock split, stock dividend, recapitalization,
combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without the Company’s
receipt of consideration, appropriate adjustments shall be made to (i) the total number and/or class of securities subject to this option
and (ii) the Exercise Price in order to reflect such change and thereby preclude a dilution or enlargement of benefits hereunder.


 


7.
Stockholder Rights. The holder of this option shall not have any stockholder rights with respect to the Option Shares until such
person shall have exercised the option, paid the Exercise Price and become the record holder of the purchased shares.


 


8.
Manner of Exercising Option.


 


(a)
In order to exercise this option with respect to all or any part of the Option Shares for which this option is at the time exercisable,
Optionee (or any other person or persons exercising the option) must take the following actions:


 


(i)
Execute and deliver to the Company a Purchase Agreement for the Option Shares for which the option is exercised.


 


(ii)
Pay the aggregate Exercise Price for the purchased shares in one or more of the following forms:


 


(A)
cash or check made payable to the Company; or


 


(B)
a promissory note payable to the Company, but only to the extent authorized by the Company.


 


(iii)
Should the Common Stock be registered under Section 12 of the 1934 Act at the time the option is exercised, then the Exercise Price may
also be paid as follows:


 


(A)
in shares of Common Stock held by Optionee (or any other person or persons exercising the option) for the requisite period necessary
to avoid a charge to the Company’s earnings for financial reporting purposes and valued at Fair Market Value on the Exercise Date;
or


 


(B)
to the extent the option is exercised for Option Shares, through a special sale and remittance procedure pursuant to which Optionee (or
any other person or persons exercising the option) shall concurrently provide irrevocable instructions (a) to a Company-designated brokerage
firm to effect the immediate sale of the purchased shares and remit to the Company, out of the sale proceeds available on the settlement
date, sufficient funds to cover the aggregate Exercise Price payable for the purchased shares plus all applicable income and employment
taxes required to be withheld by the Company by reason of such exercise and (b) to the Company to deliver the certificates for the purchased
shares directly to such brokerage firm in order to complete the sale.


 




    	 



     


    

 


Except
to the extent the sale and remittance procedure is utilized in connection with the option exercise, payment of the Exercise Price must
accompany the Purchase Agreement delivered to the Company in connection with the option exercise.


 


(iv)
The exercise price of the Options may also be paid, to the extent permitted by applicable statutes and regulations, either (i) in cash
at the time the Option is exercised, (ii) by delivery to the Company of other Common Stock of the Company valued at its then established
fair market value (as defined below), (iii) by delivery to the Company of either options or stock of the Company including, without limitation,
this Option, valued at the difference between their exercise price and the then established fair market value of the Company’s
Common Stock, (iv) according to a deferred payment or other arrangement (which may include, without limiting the generality of the foregoing,
the use of other Common Stock of the Company) with the holder hereof, or (v) any other form of legal consideration that may be acceptable
to the Board of Directors, in their discretion. For the purposes of this Section 4, the fair market value of the Company’s Common
Stock shall be defined as (i) the closing sale price for the Common Stock on the primary exchange upon which the shares are listed and
traded on the date prior to the date the Option is exercised, or (ii) if the shares are not traded on any national exchange, the closing
sale price for the Common Stock on the NASDAQ National Market on the date prior to the date the Option is exercised, or (iv) if the shares
are neither traded on a national exchange nor listed on the NASDAQ National Market, then the average of the bid and ask prices for the
Common Stock in the Over-The-Counter Market as quoted on the NASDAQ Capital Market, on the date prior to the date the Option is exercised,
or (iv) if the shares of Common Stock are neither traded on a national exchange or the NASDAQ National Market nor quoted on the NASDAQ
Capital Market, the average of the bid and ask prices for the Common Stock as quoted by any recognized securities quotation service such
as the OTC.QB of the OTC Markets Group, LLC or the OTC Electronic Bulletin Board on the date prior to the date the Option is exercised,
or (v) if the shares of Common Stock are not quoted on any recognized securities quotation service such as the OTC.QB of the OTC Markets
Group, LLC or the OTC Electronic Bulletin Board on the date prior to the date the Option is exercised, then the fair market value of
the Company’s Common Stock shall be the price paid for the Company’s Common Stock in the most recent transaction involving
the Company and a nonaffiliated purchaser in an arm’s length transaction (the “Fair Market Value”). In the case of
any deferred payment arrangement, any interest shall be payable at least annually and shall be charged at the minimum rate of interest
necessary to avoid the treatment as interest, under any applicable provisions of the Internal Revenue Code, of any amounts other than
amounts stated to be interest under the deferred payment arrangement.


 


(b)
By way of example, in lieu of exercising this Option by payment with cash, certified check or wired funds, the Holder may elect to receive
the number of Shares, as determined below, equal to the value of this Option (or the portion thereof being exercised) by surrender of
this Option at the corporate office of the Company together with the duly executed form of subscription agreement and notice of such
an election, in which event the Company shall issue to the Holder a number of shares of Common Stock computed using the following formula:


 


X=
Y(A-B)


A


 


	 	Where:	 	X
    = the number of shares of Common Stock to be issued to the Holder
	 	 	 	Y
    = the gross number of shares of Common Stock to be purchased
	 	 	 	A
    = the Fair Market Value of one (1) share of the Company’s Common Stock
	 	 	 	on
the date prior to exercise hereunder
	 	 	 	 
	 	 	 	B
    = Exercise Price


 




    	 



     


    

 


(v)
Furnish to the Company appropriate documentation that the person or persons exercising the option (if other than Optionee) have the right
to exercise this Option


 


(vi)
Execute and deliver to the Company such written representations as may be requested by the Company in order for it to comply with the
applicable requirements of applicable securities laws.


 


(vii)
Make appropriate arrangements with the Company (or Subsidiary or Affiliate employing or retaining Optionee) for the satisfaction of all
applicable income and employment tax withholding requirements applicable to the option exercise.


 


(b)
As soon as practical after the Exercise Date, the Company shall issue to or on behalf of Optionee (or any other person or persons exercising
this option) a certificate for the purchased Option Shares, with the appropriate legends affixed thereto.


 


(c)
In no event may this option be exercised for any fractional shares.


 


9.
Compliance with Laws and Regulations.


 


(a)
The exercise of this option and the issuance of the Option Shares upon such exercise shall be subject to compliance by the Company and
Optionee with all applicable requirements of law relating thereto and with all applicable regulations of any stock exchange (or the Nasdaq
National Market, if applicable) on which the Common Stock may be listed for trading at the time of such exercise and issuance.


 


(b)
The inability of the Company to obtain approval from any regulatory body having authority deemed by the Company to be necessary to the
lawful issuance and sale of any Common Stock pursuant to this option shall relieve the Company of any liability with respect to the non-issuance
or sale of the Common Stock as to which such approval shall not have been obtained. The Company, however, shall use its best efforts
to obtain all such approvals.


 


10.
Successors and Assigns. Except to the extent otherwise provided in Sections 3 and 6, the provisions of this Agreement shall inure
to the benefit of, and be binding upon, the Company and its successors and assigns and Optionee, Optionee’s assigns and the legal
representatives, heirs and legatees of Optionee’s estate.


 


11.
Notices. Any notice required to be given or delivered to the Company under the terms of this Agreement shall be in writing and
addressed to the Company at its principal corporate offices. Any notice required to be given or delivered to Optionee shall be in writing
and addressed to Optionee at the address indicated below Optionee’s signature line on the Grant Notice. All notices shall be deemed
effective upon personal delivery or upon deposit in the U.S. mail, postage prepaid and properly addressed to the party to be notified.


 


12.
Governing Law. The interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State of
Colorado without resort to that State’s conflict-of-laws rules.


 


 


	SELECTIS
    HEALTH, INC.	 	OPTIONEE:
	 	 	 
	By:	/s/ Lance Baller	 	/s/
    Christopher Barker
	Name:	Lance
    Baller 	 	Christopher
    Barker
	Title:	CEO	 	 



 




    	 



     


    

 


EXHIBIT
A 


 


NONSTATUTORY
STOCK OPTION AGREEMENT 


 


EXERCISE
NOTICE


 


Selectis
Health, Inc.


 


Attention:
Secretary


 


1.
Exercise of Option. Effective as of today, ___________________, _________, the undersigned (the “Optionee”) hereby
elects to exercise the Optionee’s option to purchase ___________ shares of the Common Stock (the “Shares”) of ____________
(the “Company”) under and pursuant to the Nonstatutory Stock Option Agreement dated _______________ (the “Agreement”).


 


2.
Delivery of Payment. The Optionee herewith delivers to the Company the full purchase price of the Shares, as set forth in the
Agreement, and any and all withholding taxes due in connection with the exercise of the Option (as defined in the Agreement).


 


3.
Representations of Optionee. The Optionee acknowledges that the Optionee has received, read and understood the Agreement and agrees
to abide by and be bound by its terms and conditions.


 


4.
Rights as Stockholder. Until the issuance of the Shares (as evidenced by the appropriate entry on the books of the Company or
of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder shall
exist with respect to shares not yet exercised. The Shares shall be issued to the Optionee as soon as practicable after the Option is
exercised in accordance with the Agreement.


 


5.
Tax Consultation. The Optionee understands that the Optionee may suffer adverse tax consequences as a result of the Optionee’s
purchase or disposition of the Shares. The Optionee represents that the Optionee has consulted with any tax consultants the Optionee
deems advisable in connection with the purchase or disposition of the Shares and that the Optionee is not relying on the Company for
any tax advice.


 


6.
Restrictive Legends and Stop-Transfer Orders.


 


(a)
Legends. The Optionee understands and agrees that the Company shall cause the legends set forth below or legends substantially
equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may
be required by the Company or by state or federal securities laws:


 


THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) AND MAY NOT BE OFFERED,
SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COMPANY COUNSEL
SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE THEREWITH.


 


(b)
Stop-Transfer Notices. The Optionee agrees that, in order to ensure compliance with the restrictions referred to herein, the Company
may issue appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company transfers its
own securities, it may make appropriate notations to the same effect in its own records.


 


(c)
Refusal to Transfer. The Company shall not be required (i) to transfer on its books any Shares that have been sold or otherwise
transferred in violation of any of the provisions of this Exercise Notice or (ii) to treat as owner of such Shares or to accord the right
to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred.


 




    	 



     


    

 


7.
Successors and Assigns. The Company may assign any of its rights under this Exercise Notice to single or multiple assignees, and
this Exercise Notice shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer
herein set forth, this Exercise Notice shall be binding upon the Optionee and his or her heirs, executors, administrators, successors
and assigns.


 


8.
Governing Law; Severability. This Exercise Notice is governed by and construed in accordance with the laws of the State of Colorado
without resort to that State’s conflict-of-laws rules.


 


9.
Entire Agreement. The Agreement is incorporated herein by reference. This Exercise Notice, the Agreement and the Investment Representation
Statement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all
prior undertakings and agreements of the Company and the Optionee with respect to the subject matter hereof, and may not be modified
adversely to the Optionee’s interest except by means of a writing signed by the Company and the Optionee.


 


	Submitted
    by: 	 	Accepted
    by: 
	 	 	 
	

    OPTIONEE:
    
	 

    
	

    SELECTIS
    HEALTH, INC.

	 	 	 
	

    Signature
	 

     
	By
    
	 	 	 
	CHRISTOPHER BARKER	 

     
	

    Title

	 

    Address:
    
	 

     
	 

     

	 	 

     
	 

     

	

    
	 

     
	

	

     
	

     
	 

    

	 	 	Date Received


 




    	 



     


    

 


EXHIBIT
B 


 


INVESTMENT
REPRESENTATION STATEMENT 


 


	OPTIONEE:
    	 	 	 
	 

    COMPANY:
	 

     
	 

    SELECTIS
    HEALTH, INC.
	 
	 

    SECURITIES:
	 

     
	 

    COMMON
    STOCK
	 
	 

    AMOUNT:
	 

     
	 

    
	 
	 

    DATE:
	 

     
	 

    
	 


 


In
connection with the purchase of the above-listed Securities, the undersigned Optionee represents to the Company the following:


 


(a)
The Optionee is aware of the Company’s business affairs and financial condition and has acquired sufficient information about the
Company to reach an informed and knowledgeable decision to acquire the Securities. The Optionee is acquiring these Securities for investment
for the Optionee’s own account only and not with a view to, or for resale in connection with, any “distribution” thereof
within the meaning of the Securities Act of 1933, as amended (the “ Securities Act “).


 


(b)
The Optionee acknowledges and understands that the Securities constitute “restricted securities” under the Securities Act
and have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon,
among other things, the bona fide nature of the Optionee’s investment intent as expressed herein. In this connection, the Optionee
understands that, in the view of the Securities and Exchange Commission, the statutory basis for such exemption may be unavailable if
the Optionee’s representation was predicated solely upon a present intention to hold these Securities for the minimum capital gains
period specified under tax statutes, for a deferred sale, for or until an increase or decrease in the market price of the Securities,
or for a period of one year or any other fixed period in the future. The Optionee further understands that the Securities must be held
indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. The
Optionee further acknowledges and understands that the Company is under no obligation to register the Securities. The Optionee understands
that the certificate evidencing the Securities will be imprinted with any legend required under applicable state securities laws.


 


(c)
The Optionee is familiar with the provisions of Rule 701 and Rule 144, each promulgated under the Securities Act, which, in substance,
permit limited public resale of “restricted securities” acquired, directly or indirectly, from the issuer thereof, in a non-public
offering subject to the satisfaction of certain conditions. Rule 701 provides that if the issuer qualifies under Rule 701 at the time
of the grant of the Option to the Optionee, the exercise will be exempt from registration under the Securities Act. In the event the
Company becomes subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, ninety (90) days
thereafter (or such longer period as any market stand-off agreement may require) the Securities exempt under Rule 701 may be resold,
subject to the satisfaction of certain of the conditions specified by Rule 144, including: (1) the resale being made through a broker
in an unsolicited “broker’s transaction” or in transactions directly with a market maker (as said term is defined under
the Securities Exchange Act of 1934); and, in the case of an affiliate, (2) the availability of certain public information about the
Company, (3) the amount of Securities being sold during any three month period not exceeding the limitations specified in Rule 144(e),
and (4) the timely filing of a Form 144, if applicable.


 


In
the event that the Company does not qualify under Rule 701 at the time of grant of the Option, then the Securities may be resold in certain
limited circumstances subject to the provisions of Rule 144, which requires the resale to occur not less than one year after the later
of the date the Securities were sold by the Company or the date the Securities were sold by an affiliate of the Company, within the meaning
of Rule 144; and, in the case of acquisition of the Securities by an affiliate, or by a non-affiliate who subsequently holds the Securities
less than two years, the satisfaction of the conditions set forth in sections (1), (2), (3) and (4) of the paragraph immediately above.


 




    	 



     


    

 


(d)
The Optionee further understands that in the event all of the applicable requirements of Rule 701 or 144 are not satisfied, registration
under the Securities Act, compliance with Regulation A, or some other registration exemption will be required; and that, notwithstanding
the fact that Rules 144 and 701 are not exclusive, the Staff of the Securities and Exchange Commission has expressed its opinion that
persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rules 144 or
701 will have a substantial burden of proof in establishing that an exemption from registration is available for such offers or sales,
and that such persons and their respective brokers who participate in such transactions do so at their own risk. The Optionee understands
that no assurances can be given that any such other registration exemption will be available in such event.


 


	 	Signature of Optionee: 
	 

    
	 

    
	 
	 	 	 
	 
	

    Date: